We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume |
---|---|---|---|---|---|
CAUD | Collective Audience Inc | 0.8025 | 0.4125 | 105.77% | 124,872,221 |
DCPH | Deciphera Pharmaceuticals Inc | 25.215 | 10.57 | 72.12% | 37,767,689 |
HWH | HWH International Inc | 2.5102 | 0.6902 | 37.92% | 20,983,981 |
SINT | SiNtx Technologies Inc | 0.0553 | 0.0149 | 36.88% | 120,527,788 |
TSLL | Direxion Daily TSLA Bull 2X Trust ETF | 9.49 | 2.34 | 32.73% | 52,404,016 |
TSLT | T Rex 2X Long Tesla Daily Target ETF | 12.975 | 3.20 | 32.67% | 9,218,560 |
TSLR | GraniteShares ETF Trust GraniteShares | 14.26 | 3.49 | 32.40% | 792,948 |
MULN | Mullen Automotive Inc | 3.9949 | 0.8349 | 26.42% | 27,544,046 |
SLNO | Soleno Therapeutics Inc | 47.81 | 9.92 | 26.18% | 2,244,887 |
CSSE | Chicken Soup for the Soul Entertainment Inc | 0.305047 | 0.06325 | 26.16% | 15,195,107 |
PAHC | Phibro Animal Health Corporation | 16.025 | 3.30 | 25.88% | 353,295 |
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced that it has entered into a definitive merger agreement with ONO Pharmaceutical Co., Ltd. (ONO), under which ONO will acquire all outstanding shares of Deciphera common stock for $25.60 per share in cash through a tender offer followed by a merger of Deciphera with a wholly-owned subsidiary of ONO (the “Acquisition”), for a total equity value of $2.4 billion. The boards of directors of both companies have unanimously approved the transaction.
Zoetis Inc. (NYSE:ZTS) and Phibro Animal Health Corporation (Nasdaq: PAHC) today announced that they have entered into a definitive agreement where Phibro Animal Health will acquire Zoetis’ medicated feed additive (MFA) product portfolio, certain water soluble products and related assets for $350 million, subject to customary closing adjustments. This transaction is expected to be complete in the second half of calendar year 2024.
HANGZHOU, China, April 29, 2024 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that it has entered into definitive agreements with a number of investors providing for the issuance of 0.9 million ordinary shares, at a purchase price of $1.70 per share, in a registered direct offering for aggregate gross proceeds of approximately $1.53 million. The closing of the sale of the securities is expected to occur on or about April 30, 2024, subject to ...
UMB Financial Corporation (Nasdaq: UMBF) and Heartland Financial, USA Inc. (Nasdaq: HTLF) announced today that they have entered into a definitive merger agreement under which UMB Financial Corporation (UMB) will acquire Heartland Financial USA, Inc. (HTLF), in an all-stock transaction valued at approximately $2.0 billion.
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 63,084.63 | 84.63 | 0.13% | 1.24T | 2,671,501,750 |
ETH | Ethereum | 3,181.21 | -88.79 | -2.72% | 382.38B | 2,500,458,605 |
USDT | Tether USD | 0.99989 | -0.00012 | -0.01% | 97.83B | 138,190,268 |
BNB | Binance Coin | 593.11 | 18.05 | 3.14% | 93.58B | 267,269,515 |
SOL | Solana | 136.21 | -3.90 | -2.78% | 60.13B | 712,675,247 |
STETH | stETH | 3,178.81 | -82.36 | -2.53% | 31.05B | 5,933,345 |
USDC | USD Coin | 0.9999 | -0.0001 | -0.01% | 28.07B | 590,292,499 |
XRP | Ripple | 0.5139 | 0.00389 | 0.76% | 27.93B | 265,216,258 |
DOGE | Dogecoin | 0.14325 | -0.00555 | -3.73% | 20.53B | 282,983,362 |
TONCOIN | Wrapped TON Coin | 5.30 | -0.291373 | -5.21% | 18.36B | 42,639,927 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions